The global organoids market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030. Increase in incidence and prevalence of chronic and infectious diseases, adoption of organoids as therapeutics tools, application of organoids in drug discovery & personalized medicine, and use of organoids in research & development is anticipated to propel the global organoids market.
The globe market is driven by the application of organoids as an important tool for cell biology, gene therapy, regenerative medicine, cancer research, and disease modelling. Technological advancements are expected to propel the global organoids market during the forecast period.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73363
Organoids are miniature, self-organized three-dimensional culture derived from stem cells, including pluripotent stem cells and adult stem cells. Organoids are considered replication of complex organs such as stomach, intestine, brain, kidney, lungs, and liver. Organoids are grown from stem cells of different sources, and these cells divide indefinitely and produce different types of cells. These structures resemble the miniature organs, which range from size of a hair width to five millimeters.
Organoids provide scientists a detailed understanding and view about the organ growth and formation, and offer them promising approach about the disease pathology and human development. Scientists have found organoids to be potential mini organs in the drug discovery and personalized medicine
Get Report Methodology @ https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=73363
Organoids Market: Segmentation
The global organoids market has been segmented based on type, application, source, and region. In terms of type, the global organoids market has been classified into stomach, intestine, liver, pancreas, lung, brain, kidney, and others. The intestine segment accounted for a prominent share of the market in 2019, ascribed to rise in prevalence of inflammatory bowel diseases (IBD) across the globe. For instance, the inflammatory bowel disease (IBD) has affected 300 per 100,000 people across the world.
Based on application, the global organoids market has been categorized into developmental biology, disease pathology of infectious disease, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology segment accounted for a major share of the market in 2019, owing to its consideration as primary investigative research tool of the human developmental biology. Moreover, organoids derived from embryonic stem cells offer complete understanding of the embryonic process development and insights on development of the stem cells.
In terms of source, the global organoids market has been bifurcated into pluripotent stem cells (hIPSCs) and organ-specific adult stem cells (ASCs). The pluripotent stem cells (hIPSCs) segment dominated the global organoids market in 2019, as pluripotent stem cells are preferred for the ability to divide indefinitely for conducting basic research and has wide therapeutic applications.
Organoids Market: Regional Segmentation
In terms of region, the global organoids market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global organoids market in 2019. This can be ascribed to rise in patients suffering from various diseases, increase in investment in research & development, commercialization of organoid models, and stem cell research.
Get Custom Research Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=73363
The market in Europe is likely to grow at a rapid pace during the forecast period. Development of cerebral organoids for neurological diseases and rise in prevalence of infectious and other diseases are projected to drive the organoids market in the region over the next few years. Investments in research & development on cancer, liver diseases, gastrointestinal diseases for organ regeneration, and stem cell research are likely to augment the organoids market in Europe during the forecast period.
Organoids Market: Major Players
Key players operating in the global organoids market include
- STEMCELL Technologies, Inc.
- Cellesce Ltd.
- Hubrecht Organoid Technology
- Definigen
- 3Dnamics, Inc.
- Organoid Therapeutics
- PeproTech, Inc.
- Thermo Fisher Scientific
- Corning Incorporated (Life Sciences)
- Merck KGgA
These players focus on adopting various strategies to expand product offerings and to strengthen the geographic presence across the globe. These have incorporated diverse strategies, including adoption of technological advancements, commercialization of organoids technology, alliances with universities and companies, ongoing studies related to different organoids, merger & acquisitions, and innovation to boost presence across the globe. Moreover, rise in disease prevalence across the globe would prompt companies to initiate awareness campaigns regarding the adoption of organoids for research & development, which, in turn, is projected to augment the global organoids market.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com